Form 4: Pediatrix Director McEachin Transfers Shares to Trust

Pediatrix Medical Group Director Thomas McEachin reported a transfer of 11,427 shares of common stock to a trust for which he and his spouse are trustees and beneficiaries.

Summary

• Thomas McEachin, a Director at Pediatrix Medical Group, Inc. (MD), reported a transaction on May 13, 2026.
• He transferred 11,427 shares of common stock.
• These shares were transferred to the Thomas A. McEachin Living Trust, established on April 17, 2025.
• McEachin and his spouse are both trustees and beneficiaries of this trust.
• Following the transaction, McEachin directly owns 7,196 shares and indirectly owns 66,073 shares through the trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine transfer of shares to a trust for estate planning purposes, with no indication of positive or negative performance or strategic shifts.

Positives

• Director Thomas McEachin continues to hold a significant beneficial ownership in Pediatrix Medical Group, Inc., both directly and indirectly through a trust.
• The transfer of shares to a living trust can be part of estate planning, which is a common and often positive step for individuals.

Negatives

• The filing does not indicate any negative financial performance or operational issues for Pediatrix Medical Group, Inc.

Risks

• The filing does not explicitly mention any risks. However, any transfer of securities could be subject to market fluctuations and the general risks associated with holding equity in a publicly traded company.

Future Outlook

This filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future financial performance.

Management Comments

• The filing includes an explanation that on May 13, 2026, the reporting person transferred 11,427 shares of common stock to a trust of which the reporting person and his spouse are trustees and beneficiaries.
• It also clarifies that the reporting person and his spouse are trustees and beneficiaries of the trust that holds the reported securities.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the healthcare services sector, indicating changes in beneficial ownership by company insiders like directors and officers.

Related Party Transactions

• Transfer of 11,427 shares of common stock from Thomas McEachin to the Thomas A. McEachin Living Trust, where McEachin and his spouse are trustees and beneficiaries.

Stakeholder Impact

• Shareholders: The transfer does not represent a sale of shares to the public, so the immediate impact on share price is likely minimal. It confirms continued insider interest and management of personal holdings.
• Management and Employees: No direct impact indicated.
• Creditors: No direct impact indicated.

Next Steps

• Continued monitoring of insider transactions for any further changes in beneficial ownership by Pediatrix Medical Group directors and officers.

Key Dates

Keywords

Pediatrix Medical Group, Form 4, SEC Filing, Insider Transaction, Stock Transfer, Beneficial Ownership, Thomas McEachin, Living Trust, Director